Gene Therapy M&A Appetite Provides Lift After Audentes Deal

Gene Therapy M&A Appetite Provides Lift After Audentes Deal

Source: 
Yahoo/Bloomberg
snippet: 

Biotech’s second year of red-hot takeovers is set for a strong finish as Astellas Pharma Inc.’s move to buy Audentes Therapeutics Inc. for about $3 billion comes a week after Novartis AG’s $6.8 billion deal for Medicines Co.